P Cinquin

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Coronavirus Disease

Pulmonary Arterial Hypertension

Top Venues

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Cordelia Ihl, J Giai, M Barbado, A Paris, S Touati, J P Alcaraz, S Tanguy, C Leroy, A Lehmann, B Degano, M Gavard, P Bedouch, P Pavese, A Moreau-Gaudry, M Roustit, François Boucher, P Cinquin, J P Brion
H 2 inhalation therapy in patients with moderate COVID-19 (H 2 COVID): a prospective ascending-dose phase I clinical trial. Antimicrobial agents and chemotherapy 68 (8) (2024)
Cordelia Ihl, J Giai, M Barbado, A Paris, S Touati, J P Alcaraz, S Tanguy, C Leroy, A Lehmann, B Degano, M Gavard, P Bedouch, P Pavese, A Moreau-Gaudry, M Roustit, François Boucher, P Cinquin, J P Brion
H 2 inhalation therapy in patients with moderate COVID-19 (H 2 COVID): a prospective ascending-dose phase I clinical trial. Antimicrobial agents and chemotherapy (2024)
Cordelia Ihl, J Giai, M Barbado, A Paris, S Touati, J P Alcaraz, S Tanguy, C Leroy, A Lehmann, B Degano, M Gavard, P Bedouch, P Pavese, A Moreau-Gaudry, M Roustit, François Boucher, P Cinquin, J P Brion
H 2 inhalation therapy in patients with moderate COVID-19 (H 2 COVID): a prospective ascending-dose phase I clinical trial. Antimicrobial agents and chemotherapy 68 (8) (2024)
Cordelia Ihl, J Giai, M Barbado, A Paris, S Touati, J P Alcaraz, S Tanguy, C Leroy, A Lehmann, B Degano, M Gavard, P Bedouch, P Pavese, A Moreau-Gaudry, M Roustit, François Boucher, P Cinquin, J P Brion
H 2 inhalation therapy in patients with moderate COVID-19 (H 2 COVID): a prospective ascending-dose phase I clinical trial. Antimicrobial agents and chemotherapy 68 (8) (2024)